Company Overview of TNG Pharmaceuticals, Inc.
TNG Pharmaceuticals, Inc. engages in the development of a vaccine that reduces the horn fly population. The company’s products include FlyVax, a veterinary vaccine based on recombinant protein technology, which inhibits the horn fly's ability to feed on cattle. Its vaccine counteracts the horn fly's anti-clotting agent, Thrombostasin, by triggering an immune response that clots the blood at the point of the wound. The company was founded in 2011 and is based in Louisville, Kentucky.
201 East Jefferson Street
Louisville, KY 40202
Founded in 2011
Key Executives for TNG Pharmaceuticals, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact TNG Pharmaceuticals, Inc., please visit www.flyvax.com. Company data is provided by Capital IQ. Please use this form to report any data issues.